[IMCR] YoY Annual Result on 31-Dec-2022 [#FY]

Stock
[IMCR] Immunocore Holdings plc
Announcement Date
01-Mar-2023
Financial Year
2022
Quarter
31-Dec-2022 [#FY]
Profit Trend
YoY- 68.66%
Quarter Report
IMCR's Result
IMCR's Financial Summary
View:
Show?
Annual Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
Revenue 249,428 143,737 26,520 30,114 25,669 23,654 60.13%
PBT -60,890 -44,145 -140,928 -87,360 -126,189 -88,178 -7.13%
Tax -5,603 -2,921 -9,405 -13,267 -22,258 -16,548 -19.46%
NP -55,287 -41,224 -131,523 -74,093 -103,931 -71,630 -5.04%
Tax Rate - - - - - - -
Total Cost 304,715 184,961 158,043 104,207 129,600 95,284 26.15%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
NP Margin -22.17 -28.68 -495.94 -246.04 -404.89 -302.82 -40.70%
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
EPS -1.13 -0.90 -3.10 -2.33 -3.81 -2.62 -15.47%
EPS Diluted -1.13 -0.90 -3.00 -2.33 -3.81 -2.62 -15.47%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.